HUP9902885A1 - Vaccine compositions against malaria - Google Patents
Vaccine compositions against malariaInfo
- Publication number
- HUP9902885A1 HUP9902885A1 HU9902885A HUP9902885A HUP9902885A1 HU P9902885 A1 HUP9902885 A1 HU P9902885A1 HU 9902885 A HU9902885 A HU 9902885A HU P9902885 A HUP9902885 A HU P9902885A HU P9902885 A1 HUP9902885 A1 HU P9902885A1
- Authority
- HU
- Hungary
- Prior art keywords
- vaccine compositions
- compositions against
- against malaria
- malaria
- vaccine
- Prior art date
Links
- 201000004792 malaria Diseases 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Vaccine for preventing or treating malaria comprises many malaria-derived antigens and an adjuvant that preferentially stimulates the TH1 response.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9902885A HUP9902885A3 (en) | 1997-07-31 | 1997-07-31 | Vaccine compositions against malaria |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9902885A HUP9902885A3 (en) | 1997-07-31 | 1997-07-31 | Vaccine compositions against malaria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9902885A1 true HUP9902885A1 (en) | 1999-12-28 |
| HUP9902885A3 HUP9902885A3 (en) | 2000-03-28 |
Family
ID=89999127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9902885A HUP9902885A3 (en) | 1997-07-31 | 1997-07-31 | Vaccine compositions against malaria |
Country Status (1)
| Country | Link |
|---|---|
| HU (1) | HUP9902885A3 (en) |
-
1997
- 1997-07-31 HU HU9902885A patent/HUP9902885A3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9902885A3 (en) | 2000-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199900069A1 (en) | VACCINE COMPOSITION AGAINST MALARIA | |
| GB2322801B (en) | Vaccine compositions for intranasal administration comprising chitosan and use thereof | |
| NL300311I2 (en) | Adjuvant systems and vaccines | |
| WO2004032829A3 (en) | Immunostimulatory compositions and methods of stimulating an immune response | |
| PL328858A1 (en) | Immunogenous peptides | |
| IS5329A (en) | Antigen transport system where monoglyceride or diglyceride derivatives are adjuvant | |
| BG101995A (en) | Saponin and sterol-containing vaccines | |
| EP0632099A3 (en) | Organopolysiloxane and method for the preparation thereof. | |
| IT1292841B1 (en) | METHOD AND DEVICE FOR THE ALIGNMENT OF PRODUCTS. | |
| EP0640097A4 (en) | Compositions and methods for vaccination against coronaviruses. | |
| CA2185470A1 (en) | Compositions and methods for vaccines comprising .alpha.-galactosyl epitopes | |
| ITTO991094A0 (en) | APPARATUS AND PROCEDURE FOR AUTOMATICALLY APPLYING NAIL ENAMEL. | |
| DK0765333T3 (en) | Quillajasaponin adjuvant and vaccine formulation containing it | |
| WO1999012563A3 (en) | Mucosal cytotoxic t lymphocyte responses | |
| EP0685506A3 (en) | Method for the preparation of (meth)acryloxyalkyl group-containing linear organopolysiloxane. | |
| HUP9902885A1 (en) | Vaccine compositions against malaria | |
| ZA9710205B (en) | Bacterial antigens and vaccine compositions II. | |
| WO1999016466A3 (en) | Vaccine compositions and methods of enhancing vaccine efficacy | |
| ZA997265B (en) | Leptospira vaccine antigens for the prevention of leptospirosis. | |
| AU6761301A (en) | Adjuvant composition comprising fha protein or fragment of fha protein in free form | |
| NL300165I2 (en) | Babesia vaccine. | |
| EP0563288A4 (en) | Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines | |
| WO1999027955A3 (en) | Treatment of established chronic infections and cancers | |
| MX9604401A (en) | Immunotherapeutic agent and its use. | |
| ZA988293B (en) | Compositions and methods for the treatment of tumor. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |